Expertise in
53
conditions

Dr. Jing Li

Holistic Medicine
Office
95 Trade St Ste 102, 
Aurora, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
53
conditions
Office
95 Trade St Ste 102, 
Aurora, IL 

Overview

Jing Li is a Holistic Medicine provider practicing medicine in Aurora, Illinois.

Ms. Li is highly rated in 53 conditions, according to our data. Her clinical expertise encompasses Liver Failure, Pancreatic Ductal Adenocarcinoma, Periodontitis, Osteotomy, and Endoscopy.

She is actively involved in clinical research, co-authoring 19700 peer reviewed articles and participating in 12 clinical trials.

Specialties

Holistic Medicine

Licenses

Acupuncturist in IL

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Office
95 Trade St Ste 102, Aurora, IL 60504

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Using Human Brain Connectivity to Identify the Causal Neuroanatomical Substrate of Depression Symptoms
Using Human Brain Connectivity to Identify the Causal Neuroanatomical Substrate of Depression Symptoms
Enrollment Status: Recruiting
Publish Date: April 21, 2025
Intervention Type: Behavioral, Other
Study Phase: Not Applicable
Phase I/II Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-Small Cell Lung Cancer
Phase I/II Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 20, 2026
Intervention Type: Biological, Other, Radiation, Procedure
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 1/Phase 2
A Phase II Clinical Trial Evaluating the Efficacy of Combining Thermal Ablation and Spine Stereotactic Radiosurgery for Patients With Spine Metastases With Moderate to Severe Epidural Involvement
A Phase II Clinical Trial Evaluating the Efficacy of Combining Thermal Ablation and Spine Stereotactic Radiosurgery for Patients With Spine Metastases With Moderate to Severe Epidural Involvement
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2026
Intervention Type: Other, Radiation, Procedure
Study Phase: Phase 2
A Prospective Phase III Randomized Trial to Compare Stereotactic Radiosurgery vs. Whole Brain Radiation Therapy for >/= 4 Newly Diagnosed Non-Melanoma Brain Metastases
A Prospective Phase III Randomized Trial to Compare Stereotactic Radiosurgery vs. Whole Brain Radiation Therapy for >/= 4 Newly Diagnosed Non-Melanoma Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: March 09, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 3
Stereotactic Radiosurgery (SRS) as Definitive Management for a Limited Number of Small Cell Lung Cancer (SCLC) Brain Metastasis
Stereotactic Radiosurgery (SRS) as Definitive Management for a Limited Number of Small Cell Lung Cancer (SCLC) Brain Metastasis
Enrollment Status: Active_not_recruiting
Publish Date: March 05, 2026
Intervention Type: Radiation, Other
Study Phase: Phase 2
A Phase II Trial to Determine Local Control and Neurocognitive Preservation After Initial Treatment With Stereotactic Radiosurgery (SRS) for Patients With >3 Melanoma Brain Metastases
A Phase II Trial to Determine Local Control and Neurocognitive Preservation After Initial Treatment With Stereotactic Radiosurgery (SRS) for Patients With >3 Melanoma Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: March 05, 2026
Intervention Type: Other, Radiation
Study Phase: Phase 2
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled Trial
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled Trial
Enrollment Status: Completed
Publish Date: December 01, 2025
Intervention Type: Drug
Study Drugs: Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin
Study Phase: Phase 4
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).
Enrollment Status: Completed
Publish Date: October 31, 2025
Intervention Type: Device, Other
Study Phase: Phase 3
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sitravatinib as Monotherapy and in Combination With Tislelizumab in Patients With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer
A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sitravatinib as Monotherapy and in Combination With Tislelizumab in Patients With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer
Enrollment Status: Completed
Publish Date: October 26, 2024
Intervention Type: Drug
Study Drugs: Sitravatinib, Tislelizumab
Study Phase: Phase 1/Phase 2
View 9 Less Clinical Trials

19610 Total Publications

Study on Standardization Methods of Multi-Source Heterogeneous Data from ICU Medical Devices Based on openEHR
Study on Standardization Methods of Multi-Source Heterogeneous Data from ICU Medical Devices Based on openEHR
Journal: Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation
Published: June 24, 2026
Similar Doctors
Expertise in
42
conditions
Jun K. Li
Holistic Medicine
Expertise in
42
conditions
Jun K. Li
Holistic Medicine
Referral may be required
2441 Madiera Ln, 
Buffalo Grove, IL 
 (33.3 miles away)
847-271-9406
Languages Spoken:
English

Jun Li is a Holistic Medicine provider practicing medicine in Buffalo Grove, Illinois. Ms. Li is highly rated in 42 conditions, according to our data. Her clinical expertise encompasses Liver Failure, PIK3CA-Related Overgrowth Spectrum, Pancreatic Ductal Adenocarcinoma, Endoscopy, and Hepatectomy.

Expertise in
57
conditions
Dr. Vimal Patel
Holistic Medicine
Expertise in
57
conditions
Dr. Vimal Patel
Holistic Medicine
Referral may be required

Physicians Express

2000 W. Main St., Suite M, 
St. Charles, IL 
 (13.1 miles away)
630-584-9242
Languages Spoken:
English
See accepted insurances

Vimal Patel is a primary care provider, practicing in Holistic Medicine in St. Charles, Illinois. Mr. Patel is highly rated in 57 conditions, according to our data. His clinical expertise encompasses Tracheitis, Sinusitis, Cellulitis, and Empyema.

Expertise in
20
conditions
Dr. Raymond Dipasquo
Holistic Medicine
Expertise in
20
conditions
Dr. Raymond Dipasquo
Holistic Medicine
Referral may be required

Office

12701 W 143rd St Ste 250, 
Homer Glen, IL 
 (16.5 miles away)
708-301-1400
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Raymond Dipasquo is a primary care provider, practicing in Holistic Medicine in Homer Glen, Illinois. Mr. Dipasquo is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Vitamin D Deficiency, Sitosterolemia, Infant Hyperglycemia, High Cholesterol, and Hernia Surgery.

Frequently Asked Questions about Dr. Jing Li

How do I make an appointment with Dr. Jing Li?

You can book an appointment with Dr. Jing Li by calling their office at 630-854-7084. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jing Li a top-rated expert for Osteotomy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jing Li is classified as an Elite expert for Osteotomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jing Li specialize in?

While Dr. Jing Li is a Holistic Medicine, they have specific expertise in Osteotomy, Endoscopy, and Liver Failure. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Holistic Medicine.

Does Dr. Jing Li participate in research or clinical trials?

Yes. Dr. Jing Li has published 19610 articles and abstracts on conditions like Osteotomy. You can view a list of Dr. Jing Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Li's expertise for a condition
ConditionClose
View All 15 Distinguished Conditions
View All 36 Advanced Conditions
View All 59 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile